EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieVergleichsstudie

Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions

Sandeep Arunothayaraj iD, Mohaned Egred iD, Adrian P Banning iD, Philippe Brunel, Miroslaw Ferenc, Thomas Hovasse, Adrian Wlodarczak iD, Manuel Pan iD, Thomas Schmitz, Marc Silvestri, Andreis Erglis iD, Evgeny Kretov iD und 10 weitere

Circulation · 04.03.2025 · 151 (9) · 612-622

DOI: 10.1161/circulationaha.124.071153 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, erschienen am 04.03.2025. Verfasst von Sandeep Arunothayaraj und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Brighton, UK (S.A., J.C., D.H.-S.). Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Artery Disease, Drug-Eluting Stents, Stents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European Bifurcation Club Left Main Trial) aimed to evaluate clinical outcomes of a stepwise provisional strategy compared with a systematic dual-stent approach. METHODS: EBC MAIN was a randomized, investigator-initiated, open-label, multicenter, parallel-group trial conducted across 35 hospitals in 11 European countries. A total of 467 participants undergoing percutaneous coronary intervention for unprotected true left main bifurcation lesions were randomly assigned to the stepwise provisional strategy (n=230) or an upfront dual-stent approach (n=237). The mean (SD) age was 71 (10) years and 23% of participants were women. The primary end point was a composite of major adverse cardiac events, defined as all-cause mortality, all myocardial infarction, or clinically driven target lesion revascularization. Events were adjudicated by an independent clinical events committee and all analyses were by the intention-to-treat principle. RESULTS: At 3 years, the primary end point occurred in 54 of 230 (23.5%) stepwise provisional and 70 of 237 (29.5%) dual-stent patients (hazard ratio, 0.75 [95% CI, 0.53–1.07]; P =0.11). There was no significant difference in all-cause mortality (10.0% versus 13.1%) or myocardial infarction (12.2% versus 11.0%). However, target lesion revascularization was significantly lower in the stepwise provisional group (8.3% versus 15.6%; hazard ratio, 0.50 [95% CI, 0.29–0.86]; P =0.013). In this population, the mean side vessel diameter by quantitative angiography was 2.9 mm, and median side vessel lesion length was 5 mm. Significant interactions were identified between the assigned bifurcation strategy and both side vessel diameter and lesion length with respect to the primary outcome ( P =0.009 and P =0.005, respectively), with smaller vessels (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionCoronary Artery DiseaseDrug-Eluting StentsStentsHumansFemaleMaleAgedMiddle AgedTreatment OutcomeEuropeMyocardial Infarction

Stichwörter der Autor:innen

angiographypercutaneous coronary interventionstents

Autor:innen und Institutionen

  • Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex NHS Trust, Brighton, UK (S.A., J.C., D.H.-S.).
  • Department of Cardiology, Freeman Hospital & Newcastle University, Newcastle upon Tyne, UK (M.E.).
  • Department of Cardiology, Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK (A.P.B.).
  • Interventional Cardiology Unit, Clinique de Fontaine, Dijon, France (P.B.).
  • Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Germany (M.F.).
  • Institute of Heart Diseases, Wroclaw Medical University, Poland (M.F.).

ORCID-Profile: Sandeep Arunothayaraj, Mohaned Egred, Adrian P Banning, Adrian Wlodarczak, Manuel Pan, Andreis Erglis, Evgeny Kretov, Jens Flensted Lassen, Alaide Chieffo, Thierry Lefèvre, Francesco Burzotta, Olivier Darremont, Goran Stankovic, David Hildick-Smith

Zitieren

APA

Arunothayaraj, S., Egred, M., Banning, A. P., Brunel, P., Ferenc, M., Hovasse, T., Wlodarczak, A., Pan, M., Schmitz, T., Silvestri, M., Erglis, A., Kretov, E., Lassen, J. F., Chieffo, A., Lefèvre, T., Burzotta, F., Cockburn, J., Darremont, O., Stankovic, G., …, & Hildick-Smith, D. (2025). Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions. Circulation, 151(9), 612-622. https://doi.org/10.1161/circulationaha.124.071153

Vancouver

Arunothayaraj S, Egred M, Banning AP, Brunel P, Ferenc M, Hovasse T, et al. Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions. Circulation. 2025;151(9):612-622. doi:10.1161/circulationaha.124.071153

BibTeX
@article{Arunothayaraj2025,
  author = {Arunothayaraj, Sandeep and Egred, Mohaned and Banning, Adrian P and Brunel, Philippe and Ferenc, Miroslaw and Hovasse, Thomas and Wlodarczak, Adrian and Pan, Manuel and Schmitz, Thomas and Silvestri, Marc and Erglis, Andreis and Kretov, Evgeny and Lassen, Jens Flensted and Chieffo, Alaide and Lefèvre, Thierry and Burzotta, Francesco and Cockburn, James and Darremont, Olivier and Stankovic, Goran and Morice, Marie-Claude and Louvard, Yves and Hildick-Smith, David},
  title = {Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions},
  journal = {Circulation},
  year = {2025},
  volume = {151},
  number = {9},
  pages = {612--622},
  doi = {10.1161/circulationaha.124.071153}
}
Kostenlos starten →